Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fattovich

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Minerva Medica|April 21, 1971
[Fetal adenoma and cancer of the thyroid gland in a patient with tuberous sclerosis (Bourneville's disease)]O Ghidini, G Fattovich, G Bellotti
Hepatology (Baltimore, Md.)|January 1, 1988
Levamisole therapy in chronic type hepatitisG Fattovich, A Alberti, G Realdi
Infection|September 1, 1992
Visceral leishmaniasis complicating chronic hepatitis B treated with interferonG Fattovich, G Giustina, F Adami
Journal of Hepatology|January 1, 1996
A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferonG Fattovich, G Giustina, S Favarato, et al.
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: patients with cirrhosisS W Schalm, G Fattovich, J T Brouwer
Clinical and Experimental Immunology|August 1, 1978
Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitisF Bortolotti, G Realdi, G Diodati, et al.
Minerva Gastroenterologica E Dietologica|March 1, 1995
[The side effects associated with the interferon-alpha therapy of chronic viral hepatitis]G Fattovich, G Giustina, S Favarato, et al.
Oncogene|June 27, 2006
Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidenceF Donato, U Gelatti, R M Limina, et al.
The American Journal of Gastroenterology|January 11, 2001
Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis CM Krampera, G Fattovich, M T Scupoli, et al.
Journal of Hepatology|October 1, 1988
Expression of preS1 and preS2 in the liver of chronic hepatitis B virus carriersA Fraiese, P Pontisso, D Cavalletto, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Minerva Medica|April 21, 1971
[Fetal adenoma and cancer of the thyroid gland in a patient with tuberous sclerosis (Bourneville's disease)]O Ghidini, G Fattovich, G Bellotti
Hepatology (Baltimore, Md.)|January 1, 1988
Levamisole therapy in chronic type hepatitisG Fattovich, A Alberti, G Realdi
Infection|September 1, 1992
Visceral leishmaniasis complicating chronic hepatitis B treated with interferonG Fattovich, G Giustina, F Adami
Journal of Hepatology|January 1, 1996
A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferonG Fattovich, G Giustina, S Favarato, et al.
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: patients with cirrhosisS W Schalm, G Fattovich, J T Brouwer
Clinical and Experimental Immunology|August 1, 1978
Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitisF Bortolotti, G Realdi, G Diodati, et al.
Minerva Gastroenterologica E Dietologica|March 1, 1995
[The side effects associated with the interferon-alpha therapy of chronic viral hepatitis]G Fattovich, G Giustina, S Favarato, et al.
Oncogene|June 27, 2006
Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidenceF Donato, U Gelatti, R M Limina, et al.
The American Journal of Gastroenterology|January 11, 2001
Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis CM Krampera, G Fattovich, M T Scupoli, et al.
Journal of Hepatology|October 1, 1988
Expression of preS1 and preS2 in the liver of chronic hepatitis B virus carriersA Fraiese, P Pontisso, D Cavalletto, et al.
Pageof 11